Article (Scientific journals)
Effects of perineural administration of ropivacaine combined with perineural or intravenous administration of dexmedetomidine for sciatic and saphenous nerve blocks in dogs.
Marolf, vincent; Ida, Keila K.; Siluk, Danuta et al.
2021In American Journal of Veterinary Research, 82 (6), p. 449-458
Peer Reviewed verified by ORBi
 

Files


Full Text
Marolf dex med 2021.pdf
Publisher postprint (707.87 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Administration, Intravenous/veterinary; Anesthetics, Local; Animals; Dexmedetomidine; Dogs; Nerve Block/veterinary; Ropivacaine; Sciatic Nerve
Abstract :
[en] OBJECTIVE: To evaluate the effects of using ropivacaine combined with dexmedetomidine for sciatic and saphenous nerve blocks in dogs. ANIMALS: 7 healthy adult Beagles. PROCEDURES: In phase 1, dogs received each of the following 3 treatments in random order: perineural sciatic and saphenous nerve injections of 0.5% ropivacaine (0.4 mL/kg) mixed with saline (0.9% NaCl) solution (0.04 mL/kg; DEX0PN), 0.5% ropivacaine mixed with dexmedetomidine (1 μg/kg; DEX1PN), and 0.5% ropivacaine mixed with dexmedetomidine (2 μg/kg; DEX2PN). In phase 2, dogs received perineural sciatic and saphenous nerve injections of 0.5% ropivacaine and an IV injection of diluted dexmedetomidine (1 μg/kg; DEX1IV). For perineural injections, the dose was divided equally between the 2 sites. Duration of sensory blockade was evaluated, and plasma dexmedetomidine concentrations were measured. RESULTS: Duration of sensory blockade was significantly longer with DEX1PN and DEX2PN, compared with DEX0PN; DEX1IV did not prolong duration of sensory blockade, compared with DEX0PN. Peak plasma dexmedetomidine concentrations were reached after 15 minutes with DEX1PN (mean ± SD, 348 ± 200 pg/mL) and after 30 minutes DEX2PN (816 ± 607 pg/mL), and bioavailability was 54 ± 40% and 73 ± 43%, respectively. The highest plasma dexmedetomidine concentration was measured with DEX1IV (1,032 ± 415 pg/mL) 5 minutes after injection. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggested that perineural injection of 0.5% ropivacaine in combination with dexmedetomidine (1 μg/kg) for locoregional anesthesia in dogs seemed to balance the benefit of prolonging sensory nerve blockade while minimizing adverse effects.
Disciplines :
Veterinary medicine & animal health
Author, co-author :
Marolf, vincent ;  Université de Liège - ULiège > FARAH
Ida, Keila K.
Siluk, Danuta
Struck-Lewicka, Wiktoria
Markuszewski, Michał J.
Sandersen, Charlotte  ;  Université de Liège - ULiège > Dépt d'Ens. et de Clinique des animaux de Compagnie (DCC) > Anesthésiologie et réanimation des animaux de compagnie
Language :
English
Title :
Effects of perineural administration of ropivacaine combined with perineural or intravenous administration of dexmedetomidine for sciatic and saphenous nerve blocks in dogs.
Publication date :
2021
Journal title :
American Journal of Veterinary Research
ISSN :
0002-9645
eISSN :
1943-5681
Publisher :
American Veterinary Medical Association, United States - Illinois
Volume :
82
Issue :
6
Pages :
449-458
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 14 January 2022

Statistics


Number of views
46 (2 by ULiège)
Number of downloads
2 (2 by ULiège)

Scopus citations®
 
12
Scopus citations®
without self-citations
11
OpenCitations
 
3

Bibliography


Similar publications



Contact ORBi